Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03717519
What this trial is testing

Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases

Who this might be right for
Colorectal CancerColorectal CarcinomaStage IV Colon Cancer
Azienda Ospedaliera Universitaria Integrata Verona 196
Not applicableStudy completedNCT05396807
What this trial is testing

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

Who this might be right for
Metastatic Colon Cancer
University of Rome Tor Vergata 106
Not applicableLooking for participantsNCT05501353
What this trial is testing

Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods

Who this might be right for
Colorectal Cancer Metastatic
Second Affiliated Hospital, Zhejiang University, School of Medicine 125
Not applicableUnknownNCT05714475
What this trial is testing

Pancreas Resection for Colorectal Metastasis: Retrospective Study

Who this might be right for
Pancreas MetastasesColorectal Cancer
Ospedale Generale Di Zona Moriggia-Pelascini 15
Testing effectiveness (Phase 2)Looking for participantsNCT06149481
What this trial is testing

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT05278728
What this trial is testing

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Biotech Pharmaceutical Co., Ltd. 31
Testing effectiveness (Phase 2)Ended earlyNCT02508077
What this trial is testing

FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colorectal CarcinomaStage IVA Colorectal CancerStage IVB Colorectal Cancer
City of Hope Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT03458975
What this trial is testing

Targeted Delivery of Chemotherapy With Ultrasound and Microbublles

Who this might be right for
Colorectal CancerHepatic Metastases
University Hospital, Tours 7
Not applicableWithdrawnNCT05175092
What this trial is testing

Living Donor Liver Transplantation for CRC Liver Metastases

Who this might be right for
Liver Metastasis Colon Cancer
University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT02959905
What this trial is testing

Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

Who this might be right for
Solid Cancer
BGI, China 11
Not applicableNot Yet RecruitingNCT05531045
What this trial is testing

18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma

Who this might be right for
Metastatic Colorectal Cancer
Assistance Publique - Hôpitaux de Paris 222
Testing effectiveness (Phase 2)Ended earlyNCT00459901
What this trial is testing

Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Peter Kozuch 13
Post-approval studies (Phase 4)Study completedNCT03700411
What this trial is testing

Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery

Who this might be right for
Colorectal CancerCirculating Tumor Cell
The Institute of Molecular and Translational Medicine, Czech Republic 125
Not applicableUnknownNCT01292681
What this trial is testing

Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Radboud University Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT05771181
What this trial is testing

Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal CancerMicrosatellite Stable Colorectal Carcinoma
Fudan University 25
Large-scale testing (Phase 3)Looking for participantsNCT07222800
What this trial is testing

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Who this might be right for
Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System Neoplasms+7 more
Pfizer 800
Testing effectiveness (Phase 2)Study completedNCT00788957
What this trial is testing

Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colon CancerColorectal CancerGastrointestinal Cancer+2 more
NantBioScience, Inc. 177
Early research (Phase 1)Study completedNCT02041481
What this trial is testing

MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
City of Hope Medical Center 26
Not applicableUnknownNCT04735900
What this trial is testing

Lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
University Hospital, Antwerp 60
Early research (Phase 1)Ended earlyNCT05743036
What this trial is testing

ZN-c3 in Adult Participants With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 44
Next Page